VIRAL RECEPTOR-DERIVED PEPTIDES AGAINST VIRAL DISEASES

    公开(公告)号:US20230312669A1

    公开(公告)日:2023-10-05

    申请号:US18173264

    申请日:2023-02-23

    CPC classification number: C07K14/705 A61P31/14

    Abstract: The present disclosure provides novel computational methods for identifying potential therapeutic peptides as antivirals, and methods of using viral receptor-derived peptides as antivirals. Further, the present disclosure provides methods of using angiotensin converting enzyme 2 (ACE2)-derived peptides as therapeutic treatments for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused coronavirus disease 2019 (COVID-19).

Patent Agency Ranking